Skip to main content

Table 4 Survival outcomes stratified by Lung-molGPA

From: Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)

Group

Number

Median survival in months

6-month probability

12-month probability

Adeno 0–1 p.

80

3.0

26

10

Adeno 1.5–2 p.

80

6.2

54

34

Adeno 2.5–3 p.

25

14.7

84

64

Adeno 3.5–4 p.

8

25.0

100

88

Other 0–1 p.

30

2.4

10

10

Other 1.5–2 p.

29

5.5

48

21

Other 2.5–3p.

18

12.5

78

56